Sensars

Lausanne, CH · 1 known investors

Sensars develops an implantable neurostimulation device that restores sensory feedback to limbs affected by diabetic neuropathy, using intra-nerve electrodes paired with smart wearable insoles to prevent complications like ulcers, falls, and amputations. The company serves diabetic patients globally with its SENSY closed-loop neuromodulation system.

Deep TechHealthtechMedical Devices